Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Radiopharmaceuticals Overview
- Preparation of Radiopharmaceuticals
- Macroeconomic Factors Analysis
- Porter’s Five Forces Analysis
- Threat of New Entrants (Moderate to Low)
- Threat of Substitutes (Low to Moderate)
- Bargaining Power of Suppliers (High)
- Bargaining Power of Buyers (Moderate)
- Industry Rivalry (Moderate)
Chapter 3 Market Dynamics
- Market Drivers
- Rising Prevalence of Cancer and Other Chronic Diseases
- Unmet Need in Oncology
- Precision Medicine
- Nuclear Imaging Technologies
- Increasing Investment
- Market Restraints
- Manufacturing and Supply Chain Issues
- Infrastructure and Specialized Imaging Equipment Requirements
- Shortage of Skilled Professionals
- Market Trends
- Theranostics
- Regional Diversification and Supply Chain Resilience
- Opportunities
- Radiopharmaceuticals Contract Manufacturing
- PET Imaging in AD
Chapter 4 Regulatory Landscape
Chapter 5 Emerging Technologies and Developments
- Emerging Technologies
- Ac-225 and Pb-212
- Nanoparticle-based Theranostic Agents
- Clinical Trials Analysis
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Patent Analysis
- Key Takeaways
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Radiopharmaceuticals Market, by Product Type
- Diagnostic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals Market, by Imaging Technique Type
- Diagnostic Radiopharmaceuticals Market, by Production Method
- Therapeutic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals Market, by Product Type
- Radiopharmaceuticals Market by Application
- Market Overview
- Oncology
- Cardiology
- Neurology
- Others
- Radiopharmaceuticals Market by Radioisotope Production Method
- Market Overview
- Market Revenue and Forecast
- Geographic Breakdown
- Radiopharmaceuticals Market Breakdown by Region
- North America
- Europe
- Asia-Pacific
- RoW
Chapter 7 Competitive Intelligence
- Overview
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
Chapter 8 Sustainability in Radiopharmaceuticals Market: ESG Perspective
- Role of ESG in the Radiopharmaceuticals Industry
- Environment
- Social
- Governance
- ESG Risk Ratings
- Conclusion
List of Tables
Summary Table: Global Market for Radiopharmaceuticals, by Region, Through 2029
Table 1: Porter’s Five Forces: Rating Scale
Table 2: Acquisitions and Funding in Radiopharmaceuticals Market, 2023 and 2024
Table 3: Selected Diagnostic Radiopharmaceuticals in Development, 2025
Table 4: Selected Novel Therapeutic Radiopharmaceuticals in Phase 3 Clinical Development, 2025
Table 5: Number of Patents for Radionuclides, January 2022-December 2024
Table 6: Number of Patents for Radionuclides, by Radionuclide Type, January 2022-December 2024
Table 7: Number of Patents for Radionuclides, by Country, January 2022-December 2024
Table 8: Global Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 9: Global Market for Diagnostic Radiopharmaceuticals, by Imaging Technique Type, Through 2029
Table 10: Commercially Available Tc-99m-based Diagnostic Radiopharmaceuticals
Table 11: Commercially Available I-123-based Diagnostic Radiopharmaceuticals
Table 12: Commercially Available In-111-based Diagnostic Radiopharmaceuticals
Table 13: Commercially Available SPECT Radiopharmaceuticals Based on Other Radionuclides
Table 14: Global Market for SPECT Radiopharmaceuticals, by Radionuclide Type, Through 2029
Table 15: PET vs. SPECT Radiopharmaceuticals
Table 16: Commercially Available F-18-based PET Radiopharmaceuticals
Table 17: Commercially Available Ga-18-based PET Radiopharmaceuticals
Table 18: Commercially Available Other PET Radiopharmaceuticals
Table 19: Global Market for PET Radiopharmaceuticals, by Radionuclide Type, Through 2029
Table 20: Global Market for Diagnostic Radiopharmaceuticals, by Production Method, Through 2029
Table 21: Common Radionuclide Pairs in Radionuclide Generators
Table 22: Global Market for Therapeutic Radiopharmaceuticals, by Product Type, Through 2029
Table 23: Lu- 177-based Therapeutic Radiopharmaceuticals
Table 24: I-131-based Therapeutic Radiopharmaceuticals
Table 25: Other Beta-emitter Radioisotope-based Therapeutic Radiopharmaceuticals
Table 26: Global Market for Beta-emitter Therapeutic Radiopharmaceuticals, by Radionuclide Type, Through 2029
Table 27: Comparison of Alpha and Beta Particles as Therapeutic Agents
Table 28: Global Market for Alpha-emitting Therapeutic Radiopharmaceuticals, Through 2029
Table 29: Global Market for Radiopharmaceuticals, by Application, Through 2029
Table 30: FDA-approved PET Radiopharmaceuticals for AD Diagnosis
Table 31: Common Nuclear Reactor-produced Radioisotopes
Table 32: Common Medical Cyclotron-produced Radioisotopes
Table 33: Global Market for Radiopharmaceuticals, by Radioisotope Production Method, Through 2029
Table 34: Global Market for Radiopharmaceuticals, by Region, Through 2029
Table 35: North American Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 36: North American Market for Diagnostic Radiopharmaceuticals, by Imaging Technique Type, Through 2029
Table 37: North American Market for Therapeutics Radiopharmaceuticals, by Product Type, Through 2029
Table 38: North American Market for Radiopharmaceuticals, by Application, Through 2029
Table 39: North American Market for Radiopharmaceuticals, by Radioisotope Production Method, Through 2029
Table 40: North American Market for Radiopharmaceuticals, by Country, Through 2029
Table 41: European Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 42: European Market for Diagnostic Radiopharmaceuticals, by Imaging Technique Type, Through 2029
Table 43: European Market for Therapeutic Radiopharmaceuticals, by Product Type, Through 2029
Table 44: European Market for Radiopharmaceuticals, by Application, Through 2029
Table 45: European Market for Radiopharmaceuticals, by Radioisotope Production Method, Through 2029
Table 46: European Market for Radiopharmaceuticals, by Country, Through 2029
Table 47: Asia-Pacific Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 48: Asia-Pacific Market for Diagnostic Radiopharmaceuticals, by Imaging Technique Type, Through 2029
Table 49: Asia-Pacific Market for Therapeutic Radiopharmaceuticals, by Product Type, Through 2029
Table 50: Asia-Pacific Market for Radiopharmaceuticals, by Application, Through 2029
Table 51: Asia-Pacific Market for Radiopharmaceuticals, by Radioisotope Production Method, Through 2029
Table 52: Asia-Pacific Market for Radiopharmaceuticals, by Country, Through 2029
Table 53: Number of Cyclotrons Used for Radionuclide Production, by Country, 2025
Table 54: RoW Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 55: RoW Market for Diagnostic Radiopharmaceuticals, by Imaging Technique Type, Through 2029
Table 56: RoW Market for Therapeutic Radiopharmaceuticals, by Product Type, Through 2029
Table 57: RoW Market for Radiopharmaceuticals, by Application, Through 2029
Table 58: RoW Market for Radiopharmaceuticals, by Radioisotope Production Method, Through 2029
Table 59: RoW Market for Radiopharmaceuticals, by Sub-region, Through 2029
Table 60: ESG Risk Rankings for Radiopharmaceutical Companies, 2025*
Table 61: Report Sources
Table 62: Abbreviations Used in This Report
Table 63: Bayer AG: Company Snapshot
Table 64: Bayer AG: Financial Performance, FY 2022 and 2023
Table 65: Bayer AG: Product Portfolio
Table 66: Bayer AG: News/Key Developments, 2023 and 2024
Table 67: Blue Earth Diagnostics: Company Snapshot
Table 68: Blue Earth Diagnostics: Product Portfolio
Table 69: Blue Earth Diagnostics: News/Key Developments, 2023 and 2024
Table 70: Boston Scientific Corp.: Company Snapshot
Table 71: Boston Scientific Corp.: Financial Performance, FY 2023 and 2024
Table 72: Boston Scientific Corp.: Product Portfolio
Table 73: BWXT Medical Ltd.: Company Snapshot
Table 74: BWXT Medical Ltd.: Product Portfolio
Table 75: BWXT Medical Ltd.: News/Key Developments, 2022-2025
Table 76: Cardinal Health: Company Snapshot
Table 77: Cardinal Health: Financial Performance, FY 2022 and 2023
Table 78: Cardinal Health: Product Portfolio
Table 79: Cardinal Health: News/Key Developments, 2023 and 2024
Table 80: Curium: Company Snapshot
Table 81: Curium: Product Portfolio
Table 82: Curium: News/Key Developments, 2022-2024
Table 83: Eckert & Ziegler: Company Snapshot
Table 84: Eckert & Ziegler: Financial Performance, FY 2022 and 2023
Table 85: Eckert & Ziegler: Product Portfolio
Table 86: Eckert & Ziegler: News/Key Developments, 2024 and 2025
Table 87: GE HealthCare: Company Snapshot
Table 88: GE HealthCare: Financial Performance, FY 2023 and 2024
Table 89: GE HealthCare: Product Portfolio
Table 90: GE HealthCare: News/Key Developments, 2022-2024
Table 91: International Isotopes Inc.: Company Snapshot
Table 92: International Isotopes Inc.: Financial Performance, FY 2022 and 2023
Table 93: International Isotopes Inc.: Product Portfolio
Table 94: International Isotopes Inc.: News/Key Developments, 2024
Table 95: IONETIX Corp.: Company Snapshot
Table 96: IONETIX Corp.: Product Portfolio
Table 97: IONETIX Corp.: News/Key Developments, 2023 and 2024
Table 98: Jubilant Pharmova Ltd.: Company Snapshot
Table 99: Jubilant Pharmova Ltd.: Financial Performance, FY 2022 and 2023
Table 100: Jubilant Pharmova Ltd.: Product Portfolio
Table 101: Jubilant Pharmova Ltd.: News/Key Developments, 2023 and 2024
Table 102: Lantheus: Company Snapshot
Table 103: Lantheus: Financial Performance, FY 2022 and 2023
Table 104: Lantheus: Product Portfolio
Table 105: Lantheus: News/Key Developments, 2022-2025
Table 106: NMR: Company Snapshot
Table 107: NMR: Product Portfolio
Table 108: NMR: News/Key Developments, 2024 and 2025
Table 109: Novartis AG: Company Snapshot
Table 110: Novartis AG: Financial Performance, FY 2023 and 2024
Table 111: Novartis AG: Product Portfolio
Table 112: Novartis AG: News/Key Developments, 2022-2024
Table 113: Siemens Healthineers AG: Company Snapshot
Table 114: Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 115: Siemens Healthineers AG: Product Portfolio
Table 116: Siemens Healthineers AG: News/Key Developments, 2023 and 2024
Table 117: List of Few Emerging Startups/ Market Disruptors
List of Figures
Summary Figure: Global Market Shares of Radiopharmaceuticals, by Region, 2023
Figure 1: Porter’s Five Forces Analysis
Figure 2: Radiopharmaceuticals Market Dynamics
Figure 3: Estimated New Cancer Cases, 2022-2050
Figure 4: Global Cancer Incidence, by Region, 2022 vs. 2045
Figure 5: Number of Active Clinical Trials for Diagnostic Radiopharmaceuticals, by Radioisotope Type, 2025
Figure 6: Number of Active Clinical Trials for Therapeutic Radiopharmaceuticals, by Radioisotope Type, 2025
Figure 7: Global Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 8: Global Market Shares of Diagnostic Radiopharmaceuticals, by Imaging Technique Type, 2023
Figure 9: Global Market Shares of SPECT Radiopharmaceuticals, by Radionuclide Type, 2023
Figure 10: Global Market Shares of PET Radiopharmaceuticals, by Radionuclide Type, 2023
Figure 11: Global Market Shares of Diagnostic Radiopharmaceuticals, by Production Method, 2023
Figure 12: Global Market Shares of Therapeutic Radiopharmaceuticals, by Product Type, 2023
Figure 13: Global Market Shares of Beta-emitter Therapeutic Radiopharmaceuticals, by Radionuclide Type, 2023
Figure 14: Global Market Shares of Radiopharmaceuticals, by Application, 2023
Figure 15: Global Market Shares of Radiopharmaceuticals, by Radioisotope Production Method, 2023
Figure 16: Global Market Shares of Radiopharmaceuticals, by Region, 2023
Figure 17: North American Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 18: North American Market Shares of Diagnostic Radiopharmaceuticals, by Imaging Technique Type, 2023
Figure 19: North American Market Shares of Therapeutic Radiopharmaceuticals, by Product Type, 2023
Figure 20: North American Market Shares of Radiopharmaceuticals, by Application, 2023
Figure 21: North American Market Shares of Radiopharmaceuticals, by Radioisotope Production Method, 2023
Figure 22: North American Market Shares of Radiopharmaceuticals, by Country, 2023
Figure 23: European Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 24: European Market Shares of Diagnostic Radiopharmaceuticals, by Imaging Technique Type, 2023
Figure 25: European Market Shares of Therapeutic Radiopharmaceuticals, by Product Type, 2023
Figure 26: European Market Shares of Radiopharmaceuticals, by Application, 2023
Figure 27: European Market Shares of Radiopharmaceuticals, by Radioisotope Production Method, 2023
Figure 28: European Market Shares of Radiopharmaceuticals, by Country, 2023
Figure 29: Asia-Pacific Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 30: Asia-Pacific Market Shares of Diagnostic Radiopharmaceuticals, by Imaging Technique Type, 2023
Figure 31: Asia-Pacific Market Shares of Therapeutic Radiopharmaceuticals, by Product Type, 2023
Figure 32: Asia-Pacific Market Shares of Radiopharmaceuticals, by Application, 2023
Figure 33: Asia-Pacific Market Shares of Radiopharmaceuticals, by Radioisotope Production Method, 2023
Figure 34: Asia-Pacific Market Shares of Radiopharmaceuticals, by Country, 2023
Figure 35: RoW Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 36: RoW Market Shares of Diagnostic Radiopharmaceuticals, by Imaging Technique Type, 2023
Figure 37: RoW Market Shares of Therapeutic Radiopharmaceuticals, by Product Type, 2023
Figure 38: RoW Market Shares of Radiopharmaceuticals, by Application, 2023
Figure 39: RoW Market Shares of Radiopharmaceuticals, by Radioisotope Production Method, 2023
Figure 40: RoW Market Shares of Radiopharmaceuticals, by Sub-Region, 2023
Figure 41: Global Market Shares of Diagnostic Radiopharmaceuticals, by Company, 2023
Figure 42: Global Market Shares of Therapeutic Radiopharmaceuticals, by Company, 2023
Figure 43: Bayer AG: Revenue Shares, by Business Unit, FY 2023
Figure 44: Bayer AG: Revenue Shares, by Country/Region, FY 2023
Figure 45: Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 46: Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 47: Cardinal Health: Revenue Shares, by Business Unit, FY 2023
Figure 48: Cardinal Health: Revenue Shares, by Country/Region, FY 2023
Figure 49: Cardinal Health: Revenue Shares, by Country/Region, FY 2023
Figure 50: Eckert & Ziegler: Revenue Shares, by Country/Region, FY 2023
Figure 51: GE HealthCare: Revenue Shares, by Business Unit, FY 2024
Figure 52: GE HealthCare: Revenue Shares, by Country/Region, FY 2024
Figure 53: International Isotopes Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 54: International Isotopes Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 55: Jubilant Pharmova Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 56: Jubilant Pharmova Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 57: Lantheus: Revenue Shares, by Business Unit, FY 2023
Figure 58: Novartis AG: Revenue Shares, by Business Unit, FY 2024
Figure 59: Novartis AG: Revenue Shares, by Country/Region, FY 2024
Figure 60: Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2024
Figure 61: Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2024
